1. Home
  2. GTBP vs SEED Comparison

GTBP vs SEED Comparison

Compare GTBP & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.27

Market Cap

13.0M

Sector

Health Care

ML Signal

HOLD

Logo Origin Agritech Limited

SEED

Origin Agritech Limited

HOLD

Current Price

$1.00

Market Cap

12.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTBP
SEED
Founded
1965
1997
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
13.0M
12.3M
IPO Year
2016
2005

Fundamental Metrics

Financial Performance
Metric
GTBP
SEED
Price
$0.27
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
366.9K
64.0K
Earning Date
05-15-2026
01-30-2026
Dividend Yield
N/A
N/A
EPS Growth
3.75
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.87
52 Week High
$1.37
$2.49

Technical Indicators

Market Signals
Indicator
GTBP
SEED
Relative Strength Index (RSI) 39.21 53.55
Support Level $0.27 $0.96
Resistance Level $0.49 $1.05
Average True Range (ATR) 0.02 0.03
MACD 0.00 0.00
Stochastic Oscillator 18.51 55.51

Price Performance

Historical Comparison
GTBP
SEED

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

About SEED Origin Agritech Limited

Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.

Share on Social Networks: